In vitro homogeneous and heterogeneous degradation of poly(ε-caprolactone/polyethylene glycol/L-lactide): The absence of autocatalysis and the role of enzymes
- 1 October 2006
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 79 (1) , 6-15
- https://doi.org/10.1002/jbm.a.30739
Abstract
This study investigated the in vitro degradation behavior of poly(ϵ‐caprolactone/polyethylene glycol/L‐lactide) (PCEL) in comparison with that of three other biodegradable polymers. Polymer membranes were incubated in pancreatin solution, Ringer's solution, and distilled water at 37°C for up to 20 weeks. Characterization involved measuring weight loss, observing the morphological changes by scanning electron microscopy (SEM), analyzing molecular weight using size exclusion chromatography (SEC), and studying the crystalline structure using differential scanning calorimetry (DSC). The hydrolysis in a simple aqueous solution experienced no autocatalysis, which was attributed to the high permeability of PCEL to water‐soluble degradation products. Similar degradation rates were recorded for the PCEL and poly(L,L‐lactide) (PLLA) test membranes. In the presence of pancreatin, the PCEL membrane experienced rapid heterogeneous surface erosion likely caused by the selective loss of its surface PEG components under enzymatic action. Pancreatin also substantially increased the even physical resorption of the other test polymers by eliminating autocatalysis. This study demonstrated that autocatalysis commonly experienced by poly(α‐hydroxyl acid) can be reduced through chemical formulation or high enzyme activity. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006Keywords
This publication has 33 references indexed in Scilit:
- The effect of ε-caproyl/d,l-lactyl unit composition on the hydrolytic degradation of poly(d,l-lactide-ran-ε-caprolactone)-poly(ethylene glycol)-poly(d,l-lactide-ran-ε-caprolactone)Biomaterials, 2006
- Evaluation of biodegradable synthetic scaffold coated on arterial prostheses implanted in rat subcutaneous tissueBiomaterials, 2005
- Morphology and levonorgestrel release behavior of polycaprolactone/ poly(ethylene oxide)/Polylactide tri‐component copolymeric microspheresPolymers for Advanced Technologies, 2003
- Enzymatic Biodegradation of Poly(ethylene oxide-b-ε-caprolactone) Diblock Copolymer and Its Potential Biomedical ApplicationsMacromolecules, 1999
- Synthesis and characterization of polycaprolactone / poly(ethylene oxide) / polylactide tri-component copolymersJournal of Biomaterials Science, Polymer Edition, 1999
- Degradation of poly(?-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII)Biomaterials, 1996
- Rapidly degraded terpolymers of DL‐lactide, glycolide, and ϵ‐caprolactone with increased hydrophilicity by copolymerization with polyethersJournal of Biomedical Materials Research, 1990
- Enzymatic activity toward poly(L‐lactic acid) implantsJournal of Biomedical Materials Research, 1990
- Enzymic Hydrolysis of Polylactic AcidEngineering in Medicine, 1981
- Biodegradable poly(lactic acid) polymersJournal of Biomedical Materials Research, 1971